IRONWOOD PHARMACEUTICALS, INC.
Income Statement
| Line Item | FY2010 | FY2009 |
|---|---|---|
| Revenue | $43.9M | $34.3M |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| Gross Margin | — | — |
| Operating Expenses | ||
| Research & Development | $77.5M | $76.1M |
| SG&A Expense | $27.2M | $19.0M |
| Operating Income | $-60.8M | $-60.8M |
| Operating Margin | -138.6% | -177.2% |
| Interest Expense | $196.0K | $318.0K |
| Pretax Income | $-59.4M | $-60.3M |
| Income Tax Expense | $-2.9M | $-296.0K |
| Net Income | $-51.9M | $-73.3M |
| Net Margin | -118.2% | -213.6% |
| EPS (Basic) | $-0.59 | $-0.77 |
| EPS (Diluted) | $-0.59 | $-0.77 |
| Shares Outstanding (Basic) | 89.7M | 92.5M |
| Shares Outstanding (Diluted) | 89.7M | 92.5M |
| Dividends Per Share | — | — |